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Background: TRPM4 channels are Ca2+-activated nonselective cation channels which are deeply involved in
physiological and pathological conditions. However, their trafficking mechanism and binding partners are still elusive.
Results: We have found the 14-3-3γ as a binding partner for TRPM4b using its N-terminal fragment from the yeast-two
hybrid screening. Ser88 at the N-terminus of TRPM4b is critical for 14-3-3γ binding by showing GST pull-down and
co-immunoprecipitation. Heterologous overexpression of 14-3-3γ in HEK293T cells increased TRPM4b expression
on the plasma membrane which was measured by whole-cell recordings and cell surface biotinylation experiment.
Surface expression of TRPM4b was greatly reduced by short hairpin RNA (shRNA) against 14-3-3γ. Next, endogenous
TRPM4b-mediated currents were electrophysiologically characterized by application of glutamate and 9-phenanthrol, a
TRPM4b specific antagonist in HT-22 cells which originated from mouse hippocampal neurons. Glutamate-induced
TRPM4b currents were significantly attenuated by shRNAs against 14-3-3γ or TRPM4b in these cells. Finally,
glutamate-induced cell death was greatly prevented by treatment of 9-phenanthrol or 14-3-3γ shRNA.
Conclusion: These results showed that the cell surface expression of TRPM4 channels is mediated by 14-3-3γ binding,
and the specific inhibition of this trafficking process can be a potential therapeutic target for glutamate-induced
neuronal cell death.
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The calcium ion (Ca2+) is the most abundant signaling
molecule in regulating physiological and cellular functions
[1]. Therefore, it is natural that Ca2+-permeable membrane
proteins have been vigorously studied to understand their* Correspondence: hong149@gnu.ac.kr; emhwang@kist.re.kr
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unless otherwise stated.dynamic actions: voltage-gated Ca2+ channels, Ca2+-per-
meable TRP (Transient Receptor Potential) channels,
ligand-gated Ca2+-permeable receptors (e.g., ionotrophic
glutamate receptors, purinergic receptors and nicotinic
acetylcholine receptors), and intracellular receptors such
as ryanodine and IP3 receptors [2-5]. In addition, Ca
2+-ac-
tivated K+ channels (BK, IK, and SK), and Ca2+-activated
Cl− channels (Bestrophins and Anoctamins) are getting
more attentions recently [6,7].
Although Ca2+-activated Na+ channels have yet to be
found, Ca2+-permeable non-selective cation channels are
numerous (e.g., NMDA receptors and TRPC channels).. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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nels are only a few: AMPA receptors (except for AMPA
receptors with calcium permeable unedited GluR2 subunit
or without GluR2 subunit) and TRPM4 and TRPM5
[8-11]. TRPM4 and TRPM5 have been identified as
Ca2+-activated, Ca2+-impermeable monovalent cation
channels whose activities have been first reported more
than three decades ago [12-16]. They conduct Na+ and K+
according to the concentration gradient of individual ion
when activated by membrane depolarization and an in-
crease in intracellular calcium ([Ca2+]i) [14-17]. They
belong to a subgroup (melastatin-related TRPM) of
TRP channels with six transmembrane domains which
forms a functional channel as a tetramer [18,19].
TRPM4 channels are expressed in various tissues in-
cluding brain [20-22]. Mutations in TRPM4 gene and
their consequential dysfunction have been linked to
cardiac diseases [23-25]. The increased level of TRPM4
channels has been reported in vascular endothelium
following hypoxia/ischemia, in the endothelial cells of
capillary vessels following spinal cord injury [26,27]. In
the brain, expression and/or channel activities of
TRPM4 have been detected in hippocampus, cerebellar
Purkinje cells, preBӧtzinger complex in the brainstem,
magnocellular cells in supraoptic and paraventricular
nuclei, and substantia nigra pars compacta [28-32]. Re-
cently, TRPM4 has been shown to be important in
neuronal cell death of experimental autoimmune en-
cephalomyelitis and human multiple sclerosis tissues
[31]. Therefore, understanding trafficking mechanism
of TRPM4 channels to the plasma membrane may
open the therapeutic window to intervene the underlying
TRPM4-related diseases.
Results and discussions
Identification of 14-3-3γ as a binding partner of TRPM4b
We previously reported that TRPM4 isoforms have
differential expression on the plasma membrane: the
full-length TRPM4b channels are highly localized on
the plasma membrane, in contrast, TRPM4a lacking
the N-terminal 174 amino acids is rarely present on the
plasma membrane [22]. To identify the potential binding
partner(s) for the surface expression of TRPM4b based on
this observation, we made a bait construct of the intracel-
lular N-terminal fragment (N174) of human TRPM4b
for the conventional yeast two-hybrid (Y2H) screening
(Figure 1A). Among the positive clones, we found human
14-3-3γ as a binding partner for TRPM4b (Figure 1B).
They formed a positive yeast colony in Y2H under the
non-permissive condition, while the empty vector did
not. To examine the interaction between TRPM4b and
14-3-3γ in the mammalian system, we constructed expres-
sion vectors for FLAG-tagged 14-3-3γ (FLAG-14-3-3γ)
and GFP-tagged TRPM4b (GFP-TRPM4b) or GFP-taggedN174, and co-expressed them in HEK293T cells. We then
performed co-immunoprecipitation (Co-IP) on cell lysates
with an anti-FLAG antibody and blotted with an anti-GFP
antibody. The results showed that GFP-TRPM4b was
strongly associated with FLAG-14-3-3γ (Figure 1C). The
inverse experiment with anti-GFP antibody for Co-IP and
anti-FLAG antibody for blotting showed the consistent re-
sult (see Additional file 1: Figure S1A). We then examined
the interaction between TRPM4b and 14-3-3γ at the
single-cell level to verify this interaction. We used the
bimolecular fluorescence complementation (BiFC) tech-
nique, which allows visualization of two independent
proteins in close spatial proximity [33]. We constructed
TRPM4b and 14-3-3γ, whose N- and C- termini were
fused to one complementary half of split Venus fluores-
cent protein, either N-terminal half (VN) or C-terminal
half (VC), and then both were transfected into HEK293T
cells (Figure 1D). Strong fluorescence was detected when
the split Venus halves were on complementary positions
(VC-TRPM4b and VN-14-3-3γ). The BiFC fluorescent
signal was detected at the plasma membrane of the cells,
shown in yellow (Figure 1D). In contrast, weak BiFC signal
was detected from the cells transfected with VC-TRPM4a
and VN-14-3-3γ (see Additional file 1: Figure S1B top
panel). As a negative control, when TRPM4b or 14-3-3γ
was expressed with only one half of split Venus, no
fluorescence was detected. These results suggest that an
association between TRPM4b and 14-3-3γ occurs in live
mammalian cells. We further examined that other 14-3-3
isoforms could bind to N174 by using several FLAG-tagged
14-3-3 isoforms for Co-IP with anti-FLAG and anti-GFP
antibodies. The result showed that binding of 14-3-3γ to
TRPM4b is isoform-specific (Figure 1E). BiFC experiment
using TRPM4b and 14-3-3σ produced the weak signal
(see Additional file 1: Figure S1B low panel).
Ser88 at the N-terminus of TRPM4b is critical for
14-3-3γ binding
Next, we investigated which amino acid residues of
TRPM4b are critical for 14-3-3γ binding. Through the
Motif Scan database [http://scansite.mit.edu/motifscan_seq.
phtml] three putative phosphorylation sites for 14-3-3γ
binding were predicted on the N174 (Figure 2A). To
identify the critical residue(s) for 14-3-3γ binding we
replaced Thr19, Thr42 and Ser88 sites of GFP-TRPM4b-
N174 to Ala individually (T19A, T42A, and S88A). From
GST (Glutathione-S-transferase)-pull down with these
mutants, we found that only S88A mutant proteins
failed to interact with 14-3-3γ (Figure 2B). Co-IP ex-
periment also revealed a drastic reduction in binding
of S88A mutant of TRPM4b with 14-3-3γ (Figure 2C).
In addition, a multiple sequence alignment shows that
Serine 88 of TRPM4b is highly conserved in four vertebrate
species (Figure 2D).
Figure 1 TRPM4b associates with 14-3-3γ in heterologous systems. (A) Diagram of the full length TRPM4b, a splice variant TRPM4a, and a
short TRPM4b N-terminal fragment (TRPM4b-N174) used in this study. (B) Identification of 14-3-3γ as a direct binding partner of TRPM4b in the
yeast two-hybrid system. (C) Co-IP experiment. GFP-TRPM4b (4b) or GFP-TRPM4b-N174 (N174) was transfected with or without FLAG-14-3-3γ in
HEK293T cells and cell lysates were then immunoprecipitated using anti-FLAG antibody. Immunoprecipitates were examined by Western blotting
using anti-GFP antibody (upper panel). Input represented 5% of cell lysates used in the Co-IP experiment (lower panel). (D) BiFC experiment with
VN-14-3-3γ and VC-TRPM4b, where N- and C-terminal halves of Venus fluorescent protein were fused to 14-3-3γ and TRPM4b, respectively. Intense
fluorescent signals were detected by the yellow color (arrow). Scale bar, 10 μm. (E) 14-3-3γ specifically binds to GFP-TRPM4b-N174 among seven
14-3-3 isoforms.
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Based on our result that TRPM4b binds to 14-3-3γ and
on the information that 14-3-3 proteins are deeply in-
volved in trafficking of membrane proteins [34], we
hypothesized that 14-3-3γ increases the surface expres-
sion of TRPM4b channels. In cell surface biotinylation
experiment, GFP-TRPM4b was markedly increased on theplasma membrane in the presence of HA-14-3-3γ
(Hemagglutinin-tagged 14-3-3γ); however no significant
changes in total cell lysate levels of TRPM4b were detected
(Figure 3A and B).
Next, we measured TRPM4b-mediated whole-cell
currents elicited by 1 μM ionomycin from the HEK293T
cells overexpressing GFP-TRPM4b with or without
Figure 2 Interaction of TRPM4b with 14-3-3γ may require a conserved serine phosphorylation residue. (A) Schematic diagram depicting
the membrane topology of hTRPM4b channels. Conserved phosphorylation residues (T19, T42, and S88) predicted for 14-3-3 binding were
marked in the intracellular N-terminal domain (N174). These residues are highlighted in red. (B) GST-pulldown was performed on lysates of
HEK293T cells co-expressing GST-14-3-3γ and GFP-TRPM4b-N174 or each mutant (S88A, T19A, and T42A). Cell lysates were immunoprecipitated
using anti-GST antibody and immunoprecipitates were examined by Western blotting using anti-GFP or anti-GST antibody. Input represented 5%
of cell lysates used. (C) Co-IP experiment was performed on lysates of HEK293T cells co-expressing FLAG-TRPM4b (WT) and its mutant (S88A). Cell
lysates were immunoprecipitated using anti-FLAG antibody and immunoprecipitates were examined by Western blotting using anti-GFP or anti-FLAG
antibody. Input represented 5% of cell lysates. (D) Sequence comparison of the region of conserved phosphorylation sites for 14-3-3 binding in
hTRPM4b among human, rat, mouse and Xenopus. Only Ser88 was conserved over the species.
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to +100 mV [15]. Currents were measured at 5 min
after ionomycin application and ionomycin-activated
currents were calculated by subtracting the initial currents
from them (Figure 3C and D). The current density from
cells overexpressing TRPM4b and 14-3-3γ were signifi-
cantly larger than the ones from cells overexpressing
TRPM4b alone. In addition, the currents from cells over-
expressing TRPM4b-S88A mutants were negligible and
similar to the ones from non-transfected cells. Alterna-
tively, using the pipette solution including 30 μM [Ca2+]i
the current density from the cells overexpressing both
TRPM4b and 14-3-3γ were more than two-folds larger
than those from the cells overexpressing TRPM4b alone
(see Additional file 2: Figures S2A and B).
Deficiency of 14-3-3γ reduces the surface expression of
TRPM4b in HEK293T cells
To examine the effect of depletion of endogenous 14-3-3γ
on the cell surface expression of overexpressed TRPM4bchannels, we constructed a specific shRNA against 14-3-3γ
and verified the efficiency of 14-3-3γ shRNA. There was
little 14-3-3γ protein from the cells co-transfected with
GFP-14-3-3γ cDNA and 14-3-3γ shRNA in contrast to
the cells co-transfected with scrambled (Sc) shRNA by
Western blot (Figure 4A). Endogenous 14-3-3γ mRNAs
in HEK293T cells were also efficiently knock-downed in
14-3-3γ shRNA-transfected cells as shown in RT-PCR
(Figure 4B). Next, we examined whether the surface ex-
pression of TRPM4b can be reduced by 14-3-3γ shRNA
using cell surface biotinylation experiment. As expected,
the surface expression of TRPM4b was markedly reduced
(Figure 4C and D). We examined the co-localization with
GFP-TRPM4b and DsRed-Mem, a plasma membrane
marker to determine the effect of 14-3-3γ shRNA on the
subcellular localization of TRPM4b (Figure 4E). GFP-
TRPM4b channels were highly localized at the plasma
membrane of HEK293T cells in the presence of Sc
shRNA, as evidenced by a yellow color in the enlarged
image (arrow in the top right panel), while they were less
Figure 3 The current density of TRPM4b channel is increased by 14-3-3γ co-expression. (A) Surface biotinylation experiment was
performed from HEK293T cells expressing GFP-TRPM4b with or without HA-14-3-3γ. Overexpression of 14-3-3γ markedly increased cell
surface expression of TRPM4b. (B) Summary bar graph of TRPM4b level with or without 14-3-3γ co-expression was shown as a ratio of surface to total
TRPM4b (n = 4). (C) The current densities were obtained from whole-cell currents of non-transfected HEK293T cells (black; n = 4), cells transfected with
GFP-TRPM4b (green; n = 5), cells transfected with S88A TRPM4b mutant (red; n = 10) and cells co-transfected with GFP-TRPM4b and
14-3-3γ (blue; n = 6). Currents were activated by 1 μM ionomycin and the voltage-ramp (−100 mV to +100 mV). The current densities
were calculated by subtracting the amplitude of initial currents from 1 μM ionomycin-activated currents and divided by cell capacitance.
(D) Summary bar graph of TRPM4b currents with or without 14-3-3γ co-expression was plotted at +100 mV (** p < 0.01 and ***p < 0.001). All
values are mean ± SEM.
Cho et al. Molecular Brain 2014, 7:52 Page 5 of 12
http://www.molecularbrain.com/content/7/1/52localized at the plasma membrane in the presence of
14-3-3γ shRNA (arrowhead in the middle right panel).
As shown in Figures 2B and C, TRPM4b-S88A mutant,
which 14-3-3γ interaction was greatly reduced, was also
less localized on the plasma membrane (arrowhead in
the bottom right panel). Reduced membrane localizations
of TRPM4b with 14-3-3γ shRNA and TRPM4b-S88A were
shown in a bar graph of Pearson’s correlation coefficient
(P < 0.001; Figure 4F).
Glutamate-induced activation of endogenous TRPM4b in
neuronal cells from hippocampus
Recently, the deficiency of TRPM4 has been shown
to be neuroprotective from glutamate-induced cell
death in experimental autoimmune encephalomyeli-
tis, a mouse model of human multiple sclerosis [31].
This report leads us to hypothesize that interference
of TRPM4b function via blocking its trafficking to
the plasma membrane with 14-3-3γ shRNA may have a
protective effect from glutamate neurotoxicity. To test this
hypothesis we first characterized TRPM4b-mediated cur-
rents in HT-22 cells, originated from mouse hippocampalneurons, which have been frequently used as an in vitro
model for glutamate-induced neurotoxicity [35].
We measured whole-cell currents which were elicited
by voltage-ramp pulses (400 ms) assessing from −100
mV to +100 mV from the holding potential of 0 mV.
After obtaining steady-state responses (10–20 sweeps),
glutamate (1 mM) was applied to the bath solution.
Glutamate-induced currents were elicited within 3–4
minutes upon glutamate application and they reached
near-maximal values within 10 minutes as originally
shown [16] (see Additional file 3: Figure S3A). The
glutamate-induced component had strong outward
rectification and the reversal potential was close to 0 mV
(Figure 5A and B). The current amplitude of glutamate-
induced currents depicted at 100 mV was 9.87 ± 2.0
(mean ± SEM, n = 6) folds larger than the ones before
glutamate application (Figure 5A and B). To verify
whether the glutamate-induced currents were TRPM4-
mediated, we used 9-phenanthrol, a selective TRPM4-
specific antagonist [36]. 9-phenanthrol was applied to the
bath solution 10 min after glutamate application when
near-maximal glutamate-induced currents were obtained.
Figure 4 The shRNA-mediated knockdown of 14-3-3γ reduced the surface expression of TRPM4b channels. (A) 14-3-3γ shRNA eliminated
GFP-14-3-3γ proteins on the Western blot from HEK293T cells overexpressing GFP-14-3-3γ (GFP, upper panel). Actin was used as a normalized
control. (B) 14-3-3γ shRNA reduced the level of 14-3-3γ mRNA in HEK293T cells as examined by RT-PCR. GAPDH was used as an internal control. (C)
Surface biotinylation experiment was performed from HEK293T cells expressing GFP-TRPM4b with Scrambled (Sc) or 14-3-3γ shRNA. The knockdown
of 14-3-3γ markedly decreased cell surface expression of TRPM4b. (D) Summary bar graph of TRPM4b level with Sc or 14-3-3γ shRNAs co-expression
was shown as a ratio of surface to total TRPM4b (n = 4). (E) GFP-TRPM4b was co-transfected with Sc shRNA (upper panel) or 14-3-3γ shRNA (middle
panel) in HEK293T cells with DsRed-Mem, a plasma membrane marker. Intracellular localization of GFP-TRPM4b was visualized by confocal microscopy
(left panels). GFP-TRPM4b-S88A was also shown in (bottom panel). Merged images were shown (right panel) and plasma membranes were indicated
by an arrow and arrowheads in enlarged image. Scale bars, 10 μm. (F) The Pearson’s correlation coefficient for TRPM4b with 14-3-3γ shRNA
or TRPM4b-S88A was significantly less than values obtained with Sc shRNA in HEK293T cells (P < 0.001). The Pearson’s correlation coefficient
denoting covariance of fluorescence signals was calculated using Nikon A1 software.
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μM), the glutamate-induced currents were inhibited by
82.8 ± 2.9%, which is similar to the reported percentage
of TRPM4 inhibition by 9-phenanthrol [37]. In addition,
in the presence of 9-phenanthrol, glutamate failed to
activate TRPM4b-mediated currents in HT-22 cells (see
Additional file 3: Figure S3B).
We also examined the endogenous expression of
TRPM4b in HT-22 cells by quantitative RT-PCR. As
shown in Additional file 3: Figure S3C, TRPM4b expres-
sion in HT-22 cells was comparable to its expression in
cultured hippocampal neurons. To rule out the possibility
of glutamate-induced current activation through other
than TRPM4b channels, we designed specific shRNAs
against TRPM4b and found two functional shRNA
constructs (see Additional file 3: Figure S3D). Glutamate-
elicited currents was indeed failed to be activated inHT-22 cells transfected with a specific TRPM4b shRNA
(Figure 5C and D). In summary, this data clearly showed
that HT-22 cells have functional TRPM4b channels which
can be elicited by glutamate.
Now, to examine the efficient interference of TRPM4b
trafficking with 14-3-3γ shRNA, we measured glutamate-
induced TRPM4b currents in HT-22 cells transfected with
either 14-3-3γ shRNA or Sc shRNA. In contrast to the
current amplitude of glutamate-induced TRPM4b chan-
nels in the cells transfected with Sc shRNA, the one in the
cells transfected with 14-3-3γ shRNA was drastically re-
duced even 20 min after glutamate application (P < 0.001;
Figure 5C and D).
Lastly, we asked whether inhibition of activity and traf-
ficking of TRPM4b may prevent the neuronal cells from
glutamate-induced cell death. First, we tested the effect
of 9-phenanthrol on the glutamate-induced cell death
Figure 5 Inhibition of TRPM4b channel activity increases cell survival from glutamate-mediated excitotoxicity in HT-22 cells. (A) A
representative whole-cell recording showed that the endogenous TRPM4b activation was induced by glutamate (1 mM) application and TRPM4b-activated
currents were inhibited by 9-phenanthrol in HT-22 cells. (B) The summary bar graph showed the mean values of activation of TRPM4b by
glutamate (1 mM) and its inhibition by 9-phenanthrol (100 μM) in HT-22 cells (P <0.001; n = 7). (C) Glutamate-induced TRPM4b currents in HT-22 cells
was impaired with 14-3-3γ or TRPM4b shRNAs but not with Sc shRNA (n = 6). (D) The bar graph showed that the current amplitudes of
TRPM4b channels transfected either with 14-3-3γ, TRPM4b or Sc shRNAs (P <0.001; n = 6). (E) The bar graph showed the results of MTT assay
which glutamate-induced cell death was prevented by 9-phenanthrol dose-dependently (P <0.001; n = 24). (F) The bar graph showed that
shRNA against 14-3-3γ or TRPM4b shRNAs significantly reduced glutamate-induced cell death in HT-22 cells (P <0.001; n = 24).
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channels effectively in whole-cell recordings. The great
number of HT-22 cells was killed after glutamate (5 mM)
treatment (69.57 ± 0.92% (n = 24); Figure 5E). In
comparison, the cell death was dramatically reduced
by 9-phenanthrol in a dose-dependent manner and no sig-
nificant difference in control cells (without glutamate
treatment) was detected (Figure 5E). We also examined
the effect of 14-3-3γ shRNA on the cell viability inglutamate-treated HT-22 cells. Compared to the HT-22
cells transfected with Sc shRNA, knockdowns of 14-3-3γ
and TRPM4b increased the cell survival (136.1 ± 3.6%
(n = 24) and 129.8 ± 4.6% (n = 6), respectively; Figure 5F).
14-3-3γ-mediated TRPM4b trafficking mechanism
provides a potential therapeutic target
14-3-3 proteins are one of most important ‘hub’ proteins
involved in diverse cellular processes in all eukaryotes
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systems and involved in many physiological conditions
(such as hippocampal long-term potentiation) as well as
neurodegenerative and neuropsychiatric diseases [38-41].
14-3-3 proteins bind to a lot of membrane proteins in-
cluding ion channels such as TASK-1 and TASK-3,
TRESK, KATP channels, hERG/IKr channels, NaV1.5,
CaV2.2, GABAB receptors, neuronal nicotinic α4β2 recep-
tors, NMDA receptor subunit NR2C, kainate receptor
subunit GluK2 and GluK5 [42-53]. Among isoforms, 14-
3-3γ has been shown to interact with a large-conductance
Ca2+-activated K+ (BK) channels and increases their
surface expression as shown in this study [54]. In general,
14-3-3 proteins bind to (mostly) phosphorylated target
proteins at the specific site(s) and function as a dimer
[34]. A previous study showed that PKCδ activation in-
creased the surface expression of TRPM4 channels in
vascular smooth muscle cells [55]; however, two putative
PKC phosphorylation sites are localized at the C-terminus
of TRPM4 channels [56]. Since 14-3-3γ binds to the N-
terminus of TRPM4b in this study, kinase(s) other than
PKC may be involved in 14-3-3γ-mediated trafficking of
TRPM4b channels.
A recent report showed that the glutamate-induced
neuronal cell death was absent in TRPM4 null mice [31]
and our results also clearly showed that inhibition of
TRPM4b function either by a specific inhibitor or interfer-
ing trafficking of TRPM4b channels to the plasma mem-
brane via 14-3-3γ shRNA blocked glutamate-induced
cell death (Figure 5). Therefore, TRPM4b channels can
be new therapeutic targets. R18 and difopein (dimeric
fourteen-three-three peptide inhibitor), peptide inhibitors
against 14-3-3 proteins, are available, however, specific
inhibitors against each 14-3-3 isoforms have not been
developed for the therapeutic purpose [57]. Instead, a gene
therapy using shRNA against 14-3-3γ in a cell type-
specific manner could be one promising way to ameliorate
devastating neurological diseases. Especially, 14-3-3γ
has been deeply involved in neurological diseases; in-
flammatory joint diseases [58], Alzheimer’s diseases
[59], Parkinson’s disease [60], multiple sclerosis [31],
and Creutzfeldt-Jakob disease [61,62]. Whereas TRPM4b
channels have not been studied in these diseases, 14-3-3γ-
mediated TRPM4b trafficking might be involved in the
neuronal cell death in these diseases.
Conclusions
TRPM4b channels are Ca2+-activated, Ca2+-impermeable
monovalent cation channels which are expressed in various
neuronal tissues and involved in diverse physiological con-
ditions. We have identified 14-3-3γ as a trafficking mol-
ecule for TRPM4b and Ser88 residue at the N-terminus of
TRPM4b is critical for 14-3-3γ binding. Heterologous
overexpression of 14-3-3γ showed the increased TRPM4bexpression on the plasma membrane, in contrast, the sur-
face expression of TRPM4b was greatly reduced by the
knockdown of endogenous 14-3-3γ. Glutamate-induced
TRPM4b currents and glutamate-induced neurotoxicity in
HT-22 cells were attenuated by a TRPM4b specific antag-
onist and 14-3-3γ shRNA. Taken together, these results
suggested that specific inhibition of 14-3-3γ-mediated
trafficking of TRPM4b channels provide a new therapeutic




2,5-diphenyl-2H-tetrazolium bromide (MTT) and all other
chemicals were purchased from Sigma Aldrich.
Plasmid and shRNA construction
The cDNA encoding for full-length human TRPM4b
(Genebank accession no. NM_017636), mouse TRPM4b
(Genebank accession no. NM_175130), and human 14-3-3γ
(Genebank accession no. NM_012479) were obtained by
the PCR-based gateway cloning method (Invitrogen).
The cDNAs of 14-3-3 isoforms were kindly provided by
Dr. Dukryong Kim (Gyeoungsang National University).
TRPM4b-N174 was generated from the full-length cDNA,
and its phosphorylation mutants (T19A, T42A and S88A)
were made by EZchange site directed mutagenesis kit
(Enzynomics). All constructs were cloned into several
vectors, including pDEST-EGFP-C, pDEST-mCherry-C,
pDEST-FLAG-C, pDEST-HA-C by gateway cloning. The





The N-termini of human TRPM4b (N174) was ligated
into pGBKT7 encoding for the GAL4 DNA binding do-
main (BD) and human cDNA library was cloned into
pGADT7 encoding for the activation domain (AD).
BD/TRPM4b-N174 and AD/cDNA library were co-
transformed into the yeast strain AH109 in order to
find protein-protein interactions with TRPM4b-N174.
AH109 was unable to synthesize histidine but AD/14-3-3γ
was found to grow on His minimal medium by permitting
histidine biosynthesis.
Cell culture and transfection
HEK293T and HT-22 cells were purchased from the
Korean Cell Line Bank (Seoul National University) and
cultured in DMEM (Invitrogen) supplemented with
10% fetal bovine serum (Invitrogen), 100 units per ml
penicillin-streptomycin (Invitrogen) at 37°C in a humidi-
fied atmosphere of 95% O2 and 5% CO2. Transfection of
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(Invitrogen) according to the manufacturer’s protocol.
Co-immunoprecipitation and immunoblotting
For co-immunoprecipitation, whole-cell lysates were mixed
at 4°C with 1 μg/ml anti-FLAG (M2, sigma) antibodies in
lysis buffer (in mM, 50 Tris–HCl (pH 7.4), 150 NaCl, 5
EDTA, 1 PMSF and 1% NP-40) containing a protease-
inhibitor cocktail (Roche). Immune complexes were incu-
bated by binding to mixed protein A/G PLUS-Agarose
(Santa Cruz Biotechnology) for 1 hr, and washed four times
with lysis buffer. For immunoblotting, Proteins were
separated by 10% SDS-PAGE gel and blotted onto PVDF
membranes. The blots were blocked with 5% skim-milk
in TBST at room temperature for 20 min and incubated
for overnight at 4°C with anti-GFP antibody (1:500,
Santa Cruz Biotechnology), anti-FLAG (1:1000, Sigma)
or anti-HA antibody (1:500, Roche). Blots were then
washed and incubated with horse-radish peroxidase
conjugated goat anti-mouse IgG, followed by washing
and detection of immunoreactivity with the enhanced
chemiluminescence (Amersham Biosciences).
GST pull-down experiment
To produce GST-14-3-3γ (14-3-3γ fused with Glutathione-
S-transferase) construct, the full-length human 14-3-3γ was
cloned into the pDEST15 vector (Invitrogen) via the gate-
way cloning system. GST-14-3-3γ proteins were expressed
in bacteria and purified according to the manufacturer’s
protocol (Amersham Biosciences). Cell lysates obtained
from wildtype or mutants of TRPM4b-N174 transfected
cells were incubated with GST-14-3-3γ purified from bac-
teria for 2 hrs, and then incubated with glutathione-
Sepharose 4B beads (Amersham Biosciences). After 2 hrs
incubation at 4°C, the beads were washed four times with
ice cold lysis buffer. Bound proteins were eluted with SDS
sample buffer, separated on 10% SDS–PAGE gels, and an-
alyzed by Western blot.
Cell Surface biotinylation
For surface biotinylation, the cell membrane proteins of
GFP-TRPM4b transfected HEK293T cells were biotinyl-
ated with PBS containing Sulfo-NHS-SS-biotin (Pierce) at
4°C for 30 min. After biotinylation, cells were washed with
quenching buffer (100 mM glycine in PBS) to remove ex-
cess biotin and washed three times with PBS. The cells
were then lysed and incubated with high capacity
NeutrAvidin-Agarose Resin (Thermo Science). After three
washes with lysis buffer, bound proteins are eluted by SDS
sample buffer and subjected to Western blot analysis.
Bimolecular fluorescence complementation (BIFC) experiment
TRPM4b and 14-3-3γ were cloned into bimolecular fluor-
escence complement (pBiFC)-VN173 and pBIFC-VC173vectors. HEK293T cells were co-transfected with cloned
BiFC vectors and transfected with DsRed-Mem for the de-
tection of plasma membrane. These cells were fixed with
4% paraformaldehyde for 20 min at room temperature
and mounted with Dako fluorescence mounting medium.
Venus fluorescence signals were observed by confocal
microscopy (Nikon A1).
Image analysis
Cell surface expression of TRPM4b was determined using
a confocal microscope. HEK293T cells were plated onto
glass coverslips and co-transfected with GFP-TRPM4b
and DsRed-Mem. The cells were cultured for additional
24 hrs, washed twice with PBS, and directly observed
under a confocal microscope. Pearson’s correlation coeffi-
cients were calculated from the co-localization signals at
the edge region of cells using the Nikon A1 confocal
software.
Electrophysiology
The standard solution for bath and pipette contained, in
mM: 1 MgCl2, 5.5 glucose, and 10 HEPES. Na-gluconate
(bath, 145 and pipette, 120) was used. Pipette solution
contained 10 mM EGTA and pH was adjusted with
NaOH to 7.2, while bath solution contained 2 mM CaCl2
and adjusted to pH 7.35. K+ was not included in either re-
cording or pipette solution to eliminate the Ca2+-activated
K+ channels which might be endogenously expressed in
either HT293T or HT-22 cells. In a few initial experi-
ments, tetraethylammonium (TEA, 2 mM) was added to
the bath solution, however, it did not show any difference
from the data with no TEA. Therefore, the data with and
without TEA were pooled. Patch pipettes were made from
borosilicate glass capillaries (Warner Instruments, Inc.).
Whole-cell currents were recorded using a patch clamp
amplifier (Axopatch 200B, Axon Instrument, Inc.). The
current–voltage relations were measured by applying
ramp pulses (from – 100 mV to +100 mV during 400 ms)
from a holding potential of 0 mV at room temperature.
The sampling interval was 200 μs and the filter setting
was 2 KHz. Currents were analyzed with Clampfit software
(Axon instruments, Inc.). Ionomycin (1 μM) was used to
activate TRPM4b channels overexpressed in HEK293T
cells. The current densities were calculated by subtracting
the amplitude of initial currents from activated TRPM4b
currents and divided by cell capacitance. A TRPM4b inhibi-
tor, 9-phenanthrol (100 μM) was applied when glutamate-
induced TRPM4b currents reached to near maximum
values (usually 10 – 20 minutes after glutamate (1 mM) ap-
plication) to measure the inhibition in HT-22 cells.
Real-time quantitative RT-PCR (qRT-PCR)
Total RNA was isolated from HT-22 cells and primary
cultured hippocampal neurons using a RNA purification
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tion. The cDNA was synthesized from 1 μg of total RNA
and reverse transcription was performed with SuperScript®
VILO™ cDNA Synthesis Kit (Invitrogen). The qRT-PCR
was done with a SensiFAST™ Probe Hi-ROX Kit (Bioline)
using the TaqMan probe Mm.PT.58.8488376 (IDT).
GAPDH was used as an endogenous control. The 2-ΔΔCt
method was used to calculate fold changes in gene expres-
sion [63].
MTT cell viability experiment
Cell viability of HT-22 cells was assessed by MTT assay
[64]. 9-phenanthrol (1, 3 and10 μM) was applied 30 min
before incubating in glutamate (5 mM) for 18 hr. After
treatment, MTT reagent (5 mg/ml in PBS) was added to
the culture wells, incubated for 3 hr, and the samples
were lysed with Dimethyl Sulfoxide (DMSO). MTT is
reductively converted into a violet formazan derivative,
which is quantified photometrically at 570 nm in a well
plate reading system (Infinite M200 pro). The mean
values from the readings of triplicate wells were taken as
one value. The optical density value for the control cultures
was considered as 100% viability (control) and viability in
other samples is expressed as a percentage of viability in
the control culture.
Statistical analysis
Numerical data are presented as means ± SEM. Error bars
in graphs denote the standard error of the mean. The
statistical significance of data was assessed by unpaired
or paired Student’s t-test. The significance level is displayed
as asterisks (*P < 0.05 or **P < 0.01, ***p < 0.001).
Additional files
Additional file 1: Figure S1. (A) Inverse Co-IP experiment. GFP-TRPM4b
(4b) or GFP-TRPM4b-N174 (N174) was transfected with or without
FLAG-14-3-3γ in HEK293T cells and cell lysates were then immunoprecipitated
using anti-GFP antibody. Immunoprecipitates were examined by Western
blotting using anti-FLAG antibody (upper panel). Input represented 5% of
cell lysates used in the Co-IP experiment (lower panel). (B) BiFC experiment
with VC-TRPM4a with and without VN-14-3-3γ (top panel) and VN-14-3-3σ
with and without VC-TRPM4b were shown (bottom panel). Weak Venus
signals were detected by the yellow color (arrow) compared to the Figure 1D.
Scale bar, 10 μm.
Additional file 2: Figure S2. (A) The current densities were obtained
from whole-cell currents of non-transfected HEK293T cells (black; n = 7),
cells transfected with GFP-TRPM4b (green; n = 7), and cells co-transfected
with GFP-TRPM4b and 14-3-3γ (red; n = 9). Currents were activated by 30 μM
[Ca 2+]i and the voltage-ramp (−100 mV to +100 mV). These overexpressed
TRPM4b currents showed linear I-V relationships as previously shown when
high [Ca2+]i was used [15]. (B) Summary bar graph of TRPM4b currents with
or without 14-3-3γ co-expression was plotted at −100 mV and +100 mV
(***p < 0.001). All values are mean ± SEM.
Additional file 3: Figure S3. (A) Activation time-course of
TRPM4b-mediated currents elicited by glutamate (1 mM) application in
HT-22 cells (n = 6). (B) A representative trace of whole cell recording
showed that pre-incubation (5–15 min) of 9-phenanthrol (100 μM)failed to activate endogenous TRPM4b-mediated currents elicited by 10 min
application of glutamate (1 mM) in HT-22 cells (n = 4; 0.292 ± 0.139 pA/pF
increased at +100 mV). Note that raw traces were activated by voltage ramp
(−100 to +100 mV) before (black) and 10 min after (red) glutamate
application were overlapped. (C) Summary bar graph of qRT-PCR of
TRPM4b in HT-22 cells. The level of endogenous TRPM4b mRNA in
HT-22 cells was comparable to the one in mouse primary cultured
hippocampal neurons. (D) Validation of mouse TRPM4b shRNA constructs.
HEK293T cells were co-transfected with GFP-TRPM4b and TRPM4b shRNA1
or shRNA2 and their knockdown efficiency was evaluated by Western blot
using anti-GFP antibody against GFP-TRPM4b.
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